Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop "L300"
Active, not recruiting
Phase 4 Results N/ASummary of Purpose
The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 9 February 2012.
| 1 May 2010 | 4 Jun 2010 | 1 Dec 2012 | 1 Dec 2012 | 1 Nov 2011 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety Study
- Intervention: Crossover Assignment
Contacts
- Charina Icamen
charina.icamencurry@bioness.com (661) 362-6646
- Jivan Ginosian
jivan.ginosian@bioness.com (661) 362-6672
- Jacqueline Bradley
jacqueline.bradley@bioness.com (661) 362-6648
View Trial Locations
Recruitment
- Enrollment: 206
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 11 locations, 1 country
Principal Investigator
- Michael O'Dell, MD
- Diemha Hoang, MD
- Ziyad Ayyoub, MD
